BlackRock
MANE

BlackRock’s Veradermics Inc MANE Stock Holding History

BlackRock’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196M Buy
1,593,791
+1,311,180
+464% +$123M ﹤0.01% 1811
2026
Q1 		$17.8M Buy
+282,611
New +$14.3M ﹤0.01% 3150

Other funds holding MANE

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

BlackRock's MANE Position: Q2 2026 in Review

BlackRock increased its Veradermics Inc (MANE) stake by 464% in Q2 2026, buying an estimated $123M and bringing the position to 1,593,791 shares worth $196M. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

BlackRock first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • BlackRock held 1,593,791 shares of Veradermics Inc worth $196M as of Q2 2026.
  • BlackRock bought 1,311,180 Veradermics Inc shares in Q2 2026, an estimated $123M.
  • Veradermics Inc made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1811 holding.
  • BlackRock first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 45 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.